<--- Back to Details
First PageDocument Content
HIV/AIDS / Organofluorides / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Integrase inhibitors / Nevirapine / Antiretroviral drug / Zidovudine / Raltegravir / Chemistry / Organic chemistry / Medicine
Date: 2014-05-20 12:14:26
HIV/AIDS
Organofluorides
Cyclopropanes
Non-nucleoside reverse transcriptase inhibitors
Integrase inhibitors
Nevirapine
Antiretroviral drug
Zidovudine
Raltegravir
Chemistry
Organic chemistry
Medicine

Microsoft Word - CROI 2014 exposed infant final color logo.docx

Add to Reading List

Source URL: nccc.ucsf.edu

Download Document from Source Website

File Size: 504,60 KB

Share Document on Facebook

Similar Documents

BMS_Gilead_Logo_FINAL.eps

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document

New Zealand Consumer Medicine Information  Viramune Tablets and Oral Suspension Nevirapine

New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine

DocID: 1gvCL - View Document

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

DocID: 1gtrY - View Document

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

DocID: 1fNy0 - View Document

1 DECEMBER  Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

DocID: 1fw0V - View Document